165 related articles for article (PubMed ID: 1690167)
1. [Spontaneous variability of ventricular arrhythmias in follow-up of anti-arrhythmia therapy].
Schmidt G; Barthel P; Ulm K; Goedel-Meinen L; Baedeker W
Herz; 1990 Feb; 15(1):11-20. PubMed ID: 1690167
[TBL] [Abstract][Full Text] [Related]
2. [Spontaneous variability of complex ventricular extrasystoles over a period of up to 4 years].
Schmidt G; Ulm K; Goedel-Meinen L; Barthel P; Jahns G; Stief B; Klein G; Baedeker W; Blömer H
Z Kardiol; 1988 Feb; 77(2):89-92. PubMed ID: 2452524
[TBL] [Abstract][Full Text] [Related]
3. [Spontaneous variability of ventricular arrhythmias in relation to the kind and extent of underlying heart disease].
Schmidt G; Barthel P; Goedel-Meinen L; Baedeker W; Ulm K
Z Kardiol; 1988 Aug; 77(8):523-6. PubMed ID: 2459860
[TBL] [Abstract][Full Text] [Related]
4. [New aspects of the clinical use of anti-arrhythmia agents with special reference to acute therapy of ventricular tachycardia (lidocaine vs. ajmaline)].
Manz M; Mletzko R; Jung W; Lüderitz B
Herz; 1990 Apr; 15(2):79-89. PubMed ID: 2188894
[TBL] [Abstract][Full Text] [Related]
5. [Long-term variability in unsustained ventricular arrhythmias: pharmacologic and pro-arrhythmic effect].
Gaita F; Richiardi E; Bobbio M; Chiotti D; Brusca A
G Ital Cardiol; 1989 Oct; 19(10):908-12. PubMed ID: 2482213
[TBL] [Abstract][Full Text] [Related]
6. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
Zrenner B; Koller B; Rudolph W
Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
[TBL] [Abstract][Full Text] [Related]
7. [Spontaneous variability of ventricular extrasystoles: criteria for validating anti-arrhythmia therapy in relation to the length of the control interval].
Schmidt G; Goedel-Meinen L; Ulm K; Jahns G; Barthel P; Stief P; Schaudig UH; Klein G; Baedeker W; Blömer H
Z Kardiol; 1987 May; 76(5):292-5. PubMed ID: 2441534
[TBL] [Abstract][Full Text] [Related]
8. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
McKenna WJ; Kleinebenne A
Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive diagnosis of ventricular arrhythmias by means of ambulatory-ECG monitoring.
Candinas RA; Podrid PJ
Herz; 1990 Feb; 15(1):1-10. PubMed ID: 2179087
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of antiarrhythmic drug effects with simultaneous analysis of single ventricular premature contractions, couplets and salvos.
Schmidt G; Ulm K; Barthel P; Riemenschneider A; Linzmaier A; Goedel-Meinen L; Baedeker W; Blömer H
J Am Coll Cardiol; 1991 Jul; 18(1):138-43. PubMed ID: 1711061
[TBL] [Abstract][Full Text] [Related]
11. [A new method for the evaluation of the success of anti-arrhythmic drug therapy and a paradoxical drug-induced arrhythmogenic effect in individual patients].
Andresen D; von Leitner ER; Wegscheider K; Schröder R
Z Kardiol; 1984 Aug; 73(8):492-7. PubMed ID: 6208699
[TBL] [Abstract][Full Text] [Related]
12. [Dose-dependent anti-arrhythmia effect of retard metoprolol in coronary disease patients with ventricular arrhythmia].
Hartwig CA; Bethge KP; Wenzlaff P; Lichtlen PR
Z Kardiol; 1988 Nov; 77(11):704-12. PubMed ID: 2463717
[TBL] [Abstract][Full Text] [Related]
13. [The role of Holter monitoring and electrophysiological studies in the evaluation of ventricular anti-arrhythmia agents].
Frank R; Raguin D; Tonet J; Fontaine G
Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():21-5. PubMed ID: 1726995
[TBL] [Abstract][Full Text] [Related]
14. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
Bluschke V; Breithardt G; Abendroth RR; Seipel L
Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
[TBL] [Abstract][Full Text] [Related]
15. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
[TBL] [Abstract][Full Text] [Related]
16. [Effect of barucainide on left ventricular ejection fraction in patients with ventricular cardiac arrhythmias].
Scheininger M; Dziersk J; Kullak W; Kors A; Köhler JA; Theisen K
Z Kardiol; 1991 Oct; 80(10):630-6. PubMed ID: 1722935
[TBL] [Abstract][Full Text] [Related]
17. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
18. [Long-term drug therapy of arrhythmias (with special reference to ventricular tachyarrhythmias].
Gertsch M
Schweiz Med Wochenschr; 1984 Jan; 114(3):77-86. PubMed ID: 6199838
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
[TBL] [Abstract][Full Text] [Related]
20. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
